US Stock MarketDetailed Quotes

SUPN Supernus Pharmaceuticals

Watchlist
  • 37.740
  • -0.130-0.34%
Close Jan 17 16:00 ET
  • 37.740
  • 0.0000.00%
Post 16:02 ET
2.08BMarket Cap35.37P/E (TTM)

Supernus Pharmaceuticals Key Stats

Supernus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 143.450M--
--2024/Q4-- / 154.252M--
Nov 4, 20242024/Q3175.689M / 157.298M--
Aug 6, 20242024/Q2168.325M / 148.852M--
May 8, 20242024/Q1143.644M / 145.832M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 143.450M--
--2024/Q4-- / 154.252M--
Nov 4, 20242024/Q3175.689M / 157.298M--
Aug 6, 20242024/Q2168.325M / 148.852M--
May 8, 20242024/Q1143.644M / 145.832M--

Unlock Free Earnings Estimates

Supernus Pharmaceuticals Earnings Reports

Read more

Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Analysis

Analyst Rating

Updated: Jan 6, 2025

Buy

  • Buy

    60.00%
  • Hold

    40.00%
  • Sell

    0.00%

Price Target

No Data